AML diagnostics in the 21st century: Use of AI
Torsten Haferlach(Martin Luther Christian University), Jan Moritz Middeke(Fresenius (Germany)), Christian Pohlkamp(Munich Leukemia Laboratory (Germany)), Wencke Walter(Munich Leukemia Laboratory (Germany)), Jakob Nikolas Kather(Heidelberg University), Sven Maschek(Munich Leukemia Laboratory (Germany)), Jan‐Niklas Eckardt(Klinik und Poliklinik für Psychotherapie und Psychosomatik)
Cited by 11
Related Papers
Deep learning can predict microsatellite instability directly from histology in gastrointestinal cancer
|Nature Medicine|2019|1.4k
Predicting survival from colorectal cancer histology slides using deep learning: A retrospective multicenter study
|PLoS Medicine|2019|1k
Minimal/measurable residual disease in AML: a consensus document from the European LeukemiaNet MRD Working Party
|Blood|2018|1k
The future landscape of large language models in medicine
|Communications Medicine|2023|937